Atlas Trials

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

Clinical trial NCT04510311 · COMPLETED

Trial details

NCT number
NCT04510311
Sponsor
University of Michigan Rogel Cancer Center
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Neuroendocrine Tumors
Start date
2020-10-19
Primary completion
2024-12-31
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.